Lincoln Pharmaceuticals Limited — Important, 28-03-2025: General Updates

Lincoln Pharmaceuticals has received cautionary letters from the National Stock Exchange and BSE regarding a delay in notifying the schedule for an Investors/Analysts Meet. While the correspondence underscores the importance of timely disclosures, it has been clarified that there is no material impact on the company's financials or operations from this incident. The company is committed to adhering to compliance measures to prevent future occurrences. Investors may view this as a call for vigilance but with no significant changes to the company's overall outlook or strategy.